When a protocol moves from one laboratory to another, the receiving team often receives a purity percentage and little else. That figure can look reassuring, but purity without identity is an incomplete claim about a research material. A vial can be 99% pure by area percentage on an HPLC trace and still be the wrong compound, the wrong batch, or a material whose identity has not been linked to the document supplied with it. For controlled in-vitro research, identity testing has to sit beside the purity number at every handover, not behind it.
All materials discussed here are research-use-only, not for human or veterinary use, and must be handled only within an in-vitro laboratory workflow.
What a Purity Percentage Can and Cannot Tell a Receiving Laboratory
Purity is a proportion, not a name
A purity percentage usually describes the proportion of a peak or signal attributed to the main component within a defined analytical method. It is useful for comparing batch consistency and spotting gross impurities. It does not, by itself, establish that the main peak is the intended peptide. Identity testing asks a different question: is this the correct molecular entity? A certificate of analysis that states both purity and identity gives the receiving laboratory two anchors rather than one.
That distinction becomes critical when a protocol is transferred because the receiving lab may be comparing a new batch against an older batch from a different production run. The older vial may have been characterised months earlier, with its own CoA and label reference. The new vial may arrive with a similar purity figure but a different batch record. Without an identity check tied to the batch, the receiving lab has no reliable way to confirm that the material matches the original specification. The purity percentage is a quality indicator, not a substitute for identity confirmation.
Why transfer amplifies the identity gap
During protocol transfer, the receiving lab may use different equipment, operators, diluents, glassware, temperature control and assay timings. Small changes can shift retention times or peak shape. If identity is not recorded, a shifted retention time may be misread as a method problem when it is actually a material or documentation problem. The identity result on the batch CoA is a reference point that lets the receiving lab separate method drift from material mismatch.
A high purity number can also mask mislabelling. If a vial contains the wrong peptide but the main peak is clean, the purity figure may still look acceptable. Identity testing is the control that catches that scenario. This is why a transfer should not reduce the material specification to a single number. Research Sciences publishes lines such as “≥99% Verified Purity” and refers to batch-level analytical verification supporting purity, identity and contaminant screening. Those are the supplier’s published claims at the time of writing; the exact purity and identity details for a specific vial should be reconfirmed against the batch CoA. The receiving lab should read the CoA, not treat a headline percentage as a batch-specific result.
In practice, the question is not “is it 99%?” but “is it 99% of the expected material, with identity confirmed on the document for this batch?” That distinction matters every time a protocol changes hands, and it applies equally whether the protocol lists BPC-157 10mg, TB-500 5mg, Ipamorelin 5mg or another research-use-only catalogue item. The materials remain not for human or veterinary use.
Documentation, Batch Traceability and the Identity Gap in Protocol Transfer
The ITR and cap-colour trap
A protocol transfer is also a documentation transfer. The receiving lab needs the batch-specific CoA, label reference, storage history, handling SOP and any deviation notes. The label reference format combines SKU code and expiry date, for example BPC10-03/27, and links to the corresponding CoA. Quoting that reference when contacting the supplier helps keep the identity and purity record aligned with the physical vial.
Batch traceability matters because restocked products may carry the same Internal Test Reference (ITR) as earlier stock. The supplier’s FAQs explain that an ITR links to associated sample testing reports; it does not confirm that separate deliveries come from the same production lot or have had separate independent testing. Vial cap colours and other packaging may vary, and cap colour is not an indicator of identity, analytical quality or manufacturing origin. A receiving lab should therefore match the label reference and batch CoA, not rely on appearance.
A worked handover scenario
Research Sciences lists CoAs Janoshik Analytical Reports on its homepage; researchers should open and check the CoA that accompanies the specific batch rather than assuming a generic report applies. For UK laboratories comparing research-use-only catalogue items, the supplier’s published documentation—such as the CoAs listed for Uk peptides—is a starting point, not a substitute for batch-level verification.
Consider a practical example. Lab A transfers an in-vitro protocol that uses BPC-157 10mg. Lab B orders the same catalogue item but receives a different batch. Both CoAs show high purity; only the identity section and batch reference confirm that the material matches the protocol’s original specification. If Lab B accepts the purity percentage alone, an assay failure may be blamed on cell handling when the first check should have been identity and batch traceability. In another scenario, a receiving lab might compare a current vial with a restocked item that carries the same ITR. The ITR alone does not prove a shared production lot, so the batch CoA and label reference must be checked together. All such materials are strictly for controlled laboratory and analytical research and are not for human or veterinary use.
Practical Controls for Receiving Labs: Verifying Identity Before the First In-Vitro Assay
A receiving-lab checklist
Before opening any vial, the receiving lab should build a material handover checklist: batch CoA with purity and identity, label reference matching the CoA, expiry date, storage conditions and dispatch temperature record where available. Research Sciences describes temperature-aware storage and tracked UK dispatch; those are published fulfilment descriptions and should be reconfirmed at the time of ordering. Delivery times are estimates, not guarantees, and should be checked against the live site and dispatch confirmation.
On receipt, inspect packaging and label. Allow lyophilised vials to reach room temperature before opening, work in a clean environment, and remove only the amount required for the experiment. Store lyophilised material at –20°C or below, sealed with desiccant and protected from moisture, heat and light. Avoid repeated freeze–thaw cycles. Reconstituted material is less stable and should be kept at 2–8°C for short-term laboratory use. These handling steps belong inside an in-vitro bench workflow and do not change the research-use-only status of the material.
Handling and reconstitution within the bench workflow
Reconstitution is an in-vitro bench step: choose diluent volume and concentration for the assay, record the calculation, and use the supplier’s calculator only as a laboratory aid. It is not for human or veterinary dosing, and the materials are not for medical or clinical use. If the protocol uses a mixing water product from the catalogue, record the lot and handling details alongside the peptide batch record. Identity verification should be repeated at the documentation level before the first assay and at any batch change. If the protocol uses a single peptide, keep it single; the supplier’s FAQs state that blended peptides are not supplied and recommend buying peptides individually and combining only within a controlled experimental design.
A final practical check is to quote the label reference when raising any documentation query. That single step keeps identity, purity and batch traceability joined together when a protocol moves between labs. Materials remain for controlled in-vitro research only and are not for human or veterinary use.
